Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial

Background: To determine whether intracoronary pro-urokinase or tirofiban improves myocardial reperfusion during primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI). Methods: The study included patients with acute STEMI presenting within 12 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Dong, Qian, Juying, Liu, Zongjun, Xu, Yawei, Zhao, Xianxian, Qiao, Zengyong, Fang, Weiyi, Jiang, Li, Hu, Wei, Shen, Chengxing, Liang, Chun, Zhang, Qi, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364959/
https://www.ncbi.nlm.nih.gov/pubmed/34409082
http://dx.doi.org/10.3389/fcvm.2021.710994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364959/
https://www.ncbi.nlm.nih.gov/pubmed/34409082
http://dx.doi.org/10.3389/fcvm.2021.710994

Ejemplares similares